Literature DB >> 2856994

Presymptomatic diagnosis of heterozygosity for familial amyloidotic polyneuropathy by recombinant DNA techniques.

H Sasaki, Y Sakaki, Y Takagi, K Sahashi, A Takahashi, T Isobe, T Shinoda, H Matsuo, I Goto, Y Kuroiwa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2856994     DOI： 10.1016/s0140-6736(85)91985-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val----Met mutation most common to the disease.

Authors:  K Yoshioka; H Furuya; H Sasaki; M J Saraiva; P P Costa; Y Sakaki
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

Review 2.  DNA analysis in human disease.

Authors:  A F Wright
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

Review 3.  Diagnosis of genetic disease using recombinant DNA.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1986-05       Impact factor: 4.132

4.  Identification of carriers of mutant prealbumin gene associated with familial amyloidotic polyneuropathy type I by Southern blot procedures: study of six pedigrees in the Arao district of Japan.

Authors:  M Ide; S Mita; S Ikegawa; S Maeda; K Shimada; S Araki
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

5.  Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met.

Authors:  Yutaka Takaoka; Mika Ohta; Kazuhisa Miyakawa; Osamu Nakamura; Misao Suzuki; Kiyoshi Takahashi; Ken-Ichi Yamamura; Yoshiyuki Sakaki
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.